EUVIMEDEUVIMED entdecken
Crossref

Evaluating dental developmental abnormalities in osteogenesis imperfecta: associations with timing and cumulative exposure to intravenous pamidronate- a pilot study

Kübra Demir, Aslı Derya Kardelen, Ayça Aslanger, Cansu Koç, Ayşe Pınar Öztürk, Çağrı Güleç, Firdevs Baş, Elif Bahar Tuna İnce, Güven Toksoy

Clinical Oral Investigations · 2026

DOI: 10.1007/s00784-026-07194-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oral Investigations, 2026. Verfasst von Kübra Demir und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Institute of Health Sciences, Istanbul University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Pamidronate, Osteogenesis Imperfecta, Tooth Abnormalities, Bone Density Conservation Agents. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Scientific Research Projects Coordination Unit of Istanbul University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Bisphosphonates are widely used in pediatric Osteogenesis Imperfecta (OI), but their potential impact on odontogenesis is not well characterized. We examined whether intravenous pamidronate exposure is associated with specific developmental dental abnormalities in OI, with particular attention to treatment timing, duration, cumulative exposure, and gender. MATERIALS AND METHODS: Fifty-eight individuals with OI (38 treated and 20 untreated) underwent standardized clinical examination and panoramic radiography. Outcomes included enamel hypoplasia, dentinogenesis imperfecta (DI), dens evaginatus (DE), microdontia, hypodontia, taurodontism, bulbous crowns, pulpal obliteration, short roots, root dilaceration, and tooth fractures. Treated individuals were further stratified by whether treatment began before or after age two years. Associations with treatment duration and cycle count were also evaluated. RESULTS: Enamel hypoplasia occurred only in treated participants (p = 0.005). Initiation of therapy before age two years was associated with a higher prevalence of enamel hypoplasia (p = 0.036). Enamel hypoplasia showed a significant association with treatment in females (p = 0.034). Root dilaceration was the only abnormality associated with cycle count (p = 0.008). Longer treatment duration was associated with DE (p = 0.021), microdontia (p = 0.026), and pulpal obliteration (p = 0.002). CONCLUSIONS: In this exploratory pilot cohort, enamel hypoplasia showed the clearest association with pamidronate exposure, particularly when treatment began before age two years. Root dilaceration demonstrated a cumulative-exposure pattern. Other abnormalities appeared more strongly related to underlying disease severity than treatment variables. CLINICAL RELEVANCE: These findings underscore the importance of structured dental surveillance in children receiving pamidronates during early developmental windows.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PamidronateOsteogenesis ImperfectaTooth AbnormalitiesBone Density Conservation AgentsDiphosphonatesHumansFemalePilot ProjectsMaleChild, PreschoolChildRadiography, PanoramicInfantAdolescent

Stichwörter der Autor:innen

BisphosphonateDental developmentDentinogenesis imperfectaEnamel hypoplasiaOsteogenesis imperfectaPamidronate

Substanzen

PamidronateBone Density Conservation AgentsDiphosphonates

Autor:innen und Institutionen

  • Department of Genetics, Institute of Health Sciences, Istanbul University, Istanbul, Turkey.
  • Department of Restorative Dentistry, Institute of Health Sciences, Istanbul University, Istanbul, Turkey.
  • Department of Internal Medicine, Department of Child Health and Diseases, Department of Pediatric Endocrinology, Istanbul Faculty of Medicine, Istanbul, Turkey.
  • Department of Medical Genetics, Istanbul Faculty of Medicine Basic Medical Sciences Building, 2nd Floor, Istanbul University, Millet Street, Capa - Fatih, 34093, Istanbul, Türkiye.
  • Department of Pedodontics, Faculty of Dentistry, Istanbul University, Istanbul, Turkey.
  • Department of Medical Genetics, Istanbul Faculty of Medicine Basic Medical Sciences Building, 2nd Floor, Istanbul University, Millet Street, Capa - Fatih, 34093, Istanbul, Türkiye. guven.toksoy@istanbul.edu.tr.

Förderung

  • Scientific Research Projects Coordination Unit of Istanbul University

Zitieren

APA

Demir, K., Kardelen, A. D., Aslanger, A., Koç, C., Öztürk, A. P., Güleç, Ç., Baş, F., İnce, E. B. T., & Toksoy, G. (2026). Evaluating dental developmental abnormalities in osteogenesis imperfecta: associations with timing and cumulative exposure to intravenous pamidronate- a pilot study. Clinical Oral Investigations. https://doi.org/10.1007/s00784-026-07194-y

Vancouver

Demir K, Kardelen AD, Aslanger A, Koç C, Öztürk AP, Güleç Ç, et al. Evaluating dental developmental abnormalities in osteogenesis imperfecta: associations with timing and cumulative exposure to intravenous pamidronate- a pilot study. Clinical Oral Investigations. 2026. doi:10.1007/s00784-026-07194-y

BibTeX
@article{Demir2026,
  author = {Demir, Kübra and Kardelen, Aslı Derya and Aslanger, Ayça and Koç, Cansu and Öztürk, Ayşe Pınar and Güleç, Çağrı and Baş, Firdevs and İnce, Elif Bahar Tuna and Toksoy, Güven},
  title = {Evaluating dental developmental abnormalities in osteogenesis imperfecta: associations with timing and cumulative exposure to intravenous pamidronate- a pilot study},
  journal = {Clinical Oral Investigations},
  year = {2026},
  doi = {10.1007/s00784-026-07194-y}
}
Kostenlos starten →